Thermo Fisher Scientific to Acquire Patheon, a Leading Contract Development and Manufacturing Organization (CDMO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
Jefferies Remains Sidelined on Thermo Fisher Scientific (TMO) Following Announced Acquisition of PTHN
May 16, 2017 7:25 AM EDTJefferies reiterated a Hold rating and $175.00 price target on Thermo Fisher Scientific (NYSE: TMO) following the company's announced move to acquire PTHN. TMO is paying $35/sh in cash and assuming ~$2B of net debt, implying an EV of $7.2B.
The deal marks... More
Evercore ISI Downgrades Patheon Holdings (PTHN) to In Line Amid Takeoer
May 15, 2017 2:57 PM EDTEvercore ISI downgraded Patheon Holdings (NYSE: PTHN) from Outperform to In Line with a price target of $35.00 (from $30.50) after the company agreed to be acquired by TMO.
For an analyst ratings summary and ratings history on Patheon Holdings... More
